Throughout her research career, Parinaz has focused on studying epigenetic dysregulation, especially its importance in cancer development and treatment. She earned her PhD in 2016 from the University of Milan in collaboration with SEMM, European School of Molecular Medicine, and then joined Prof. De Carvalho’s lab at the University Health Network (UHN), Princess Margaret Cancer Centre in Toronto to pursue her postdoctoral study. In October 2021, she joined the Ludwig Institute for Cancer Research at the University of Oxford to start her independent research programme.